TY - JOUR AU - Karachaliou, Niki AU - Fernandez-Bruno, Manuel AU - Rosell, Rafael PY - 2018 TI - Strategies for first-line immunotherapy in squamous cell lung cancer: are combinations a game changer? JF - Translational Lung Cancer Research; Vol 7, Supplement 3 (September 26, 2018): Translational Lung Cancer Research1 Y2 - 2018 KW - N2 - The initial treatment for metastatic squamous cell non-small cell lung cancer (NSCLC) consists of platinum-based combination chemotherapy. The most commonly used regimens are carboplatin and paclitaxel, carboplatin and protein-bound paclitaxel (nab-paclitaxel), and cisplatin and gemcitabine. UR - https://tlcr.amegroups.org/article/view/22760